Multicenter, Randomized Phase 2B Study to Evaluate the E

Project: Research project

Project Details

Description

Multicenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety and Tolerability of OCR-002 (ornithine phenylacetate) in Hospitalized Patients with Cirrhosis and Associated Hyperammonemia with an Episode of Hepatic Encephalopathy; STOP-HE Study
StatusFinished
Effective start/end date8/12/133/31/17

Funding

  • OCERA THERAPEUTICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.